Swiss pharmaceutical company Novartis AG says it has completed its purchase of Nestle SA's 77 percent stake in eye care firm Alcon Inc. at a total cost of $38.7 billion.
novartisNovartis leukemia drug gets faster FDA reviewNewsvine - business Fri, 02/19/2010 - 08:15
Novartis AG said Friday its leukemia drug candidate Tasigna received priority review by the Food and Drug Administration. Novartis to Pay $28B For Nestle Alcon StakeTopix - Business News Mon, 01/04/2010 - 13:43
Novartis has exercised its call option to buy Nestle's remaining 52% stake in eyecare company Alcon for about $28 billion in cash. Tags:
Novartis posts 1 percent growth in 3Q net profitNewsvine - business Wed, 10/21/2009 - 23:36
Drug maker Novartis AG has posted a 1 percent increase in third-quarter net profit driven by strong sales from its pharmaceuticals division. Novartis swine flu vaccine may work on fewer dosesNewsvine - business Thu, 09/03/2009 - 02:49
Swiss drugmaker Novartis said Thursday one of its swine flu vaccines may work with just one dose, rather than two as previously expected, a finding that could potentially boost global supplies. Novartis says FDA approves interferon drug for MSNewsvine - business Mon, 08/17/2009 - 05:25
Novartis AG said Monday the U.S. Food and Drug Administration approved its drug Extavia, a form of interferon intended to treat multiple sclerosis. |
